Allosteric signaling through an mGlu2 and 5-HT 2A heteromeric receptor complex and its potential contribution to schizophrenia
Author(s) -
José L. Moreno,
Patricia MirandaAzpiazu,
Aintzane GarcíaBea,
Jason Younkin,
Meng Cui,
Alexey Kozlenkov,
Ariel Ben-Ezra,
Georgios Voloudakis,
Amanda K. Fakira,
Lia Baki,
Yongchao Ge,
Anastasios Georgakopoulos,
José A. Morón,
Graeme Milligan,
Juan F. LópezGiménez,
Nikolaos K. Robakis,
Diomedes E. Logothetis,
J. Javier Meana,
Javier GonzálezMaeso
Publication year - 2016
Publication title -
science signaling
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.659
H-Index - 154
eISSN - 1937-9145
pISSN - 1945-0877
DOI - 10.1126/scisignal.aab0467
Subject(s) - allosteric regulation , schizophrenia (object oriented programming) , receptor , microbiology and biotechnology , chemistry , biology , computational biology , neuroscience , biochemistry , psychology , psychiatry
Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) can form multiprotein complexes (heteromers), which can alter the pharmacology and functions of the constituent receptors. Previous findings demonstrated that the Gq/11-coupled serotonin 5-HT2A receptor and the Gi/o-coupled metabotropic glutamate 2 (mGlu2) receptor-GPCRs that are involved in signaling alterations associated with psychosis-assemble into a heteromeric complex in the mammalian brain. In single-cell experiments with various mutant versions of the mGlu2 receptor, we showed that stimulation of cells expressing mGlu2-5-HT2A heteromers with an mGlu2 agonist led to activation of Gq/11 proteins by the 5-HT2A receptors. For this crosstalk to occur, one of the mGlu2 subunits had to couple to Gi/o proteins, and we determined the relative location of the Gi/o-contacting subunit within the mGlu2 homodimer of the heteromeric complex. Additionally, mGlu2-dependent activation of Gq/11, but not Gi/o, was reduced in the frontal cortex of 5-HT2A knockout mice and was reduced in the frontal cortex of postmortem brains from schizophrenic patients. These findings offer structural insights into this important target in molecular psychiatry.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom